Searched for
MURALI DIVI INCOME
Buy Divi's Laboratories, target price Rs 3579: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 93390.52 Crore) operating in Pharmace...
08 Jun, 2023, 10.22 AM IST
Buy Divi's Laboratories, target price Rs 2912: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 76314.25 Crore) operating in Pharmace...
05 Apr, 2023, 09.44 AM IST
Saurabh Mukherjea is gung-ho on 2 pharma stocks; adds Prudent Corporate. Here’s whyFounder of Marcellus Investment Managers, Saurabh Mukherjea, advises investors to identify businesses with unique skill sets and distinctiv...
31 Mar, 2023, 09.04 AM IST
Motilal Oswal Financial Services neutral on Divi's Laboratories, target price-Rs 2620Promoters held 51.94 per cent stake in the company as of 31-Dec-2022, while FIIs owned 15.15 per cent, DIIs 20.5 per cent.
20 Mar, 2023, 11.23 AM IST
Sell Divi's Laboratories, target price Rs 2750: Sharekhan by BNP ParibasDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 75747.48 Crore) operating in Pharmace...
01 Mar, 2023, 09.46 AM IST
Buy Divi's Laboratories, target price Rs 3480: Reliance SecuritiesDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 90499.57 Crore) operating in Pharmace...
02 Dec, 2022, 10.34 AM IST
At Rs 58.8 cr, Murali of Divi's Lab highest paid Indian pharma executiveThe percentage increase in the median remuneration for the staff of the firm for FY19 was 3.96 per cent.
11 Aug, 2019, 02.43 PM IST